Results 331 to 333 of about 39,319 (333)
Some of the next articles are maybe not open access.

Characterization of ibrutinib‐sensitive and ‐resistant mantle lymphoma cells

British Journal of Haematology, 2014
Ailin Guo, Y Lynn Wang
exaly  

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice

British Journal of Haematology, 2018
John G Gribben   +2 more
exaly  

Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma—a “real world” study

Hematological Oncology, 2017
Narendranath Epperla   +2 more
exaly  
chronic lymphocytic leukemia
leukemia
medicine
internal medicine
oncology
lymphoma
tyrosine kinase
bruton's tyrosine kinase
receptor
previous   32  33  34  

Home - About - Disclaimer - Privacy